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A B S T R A C T
Vanillin is widely used in food and cosmetics, among other substances, for its sweet smell. However, the neu-
ropsychological effects of vanillin inhalation have not been elucidated. In this study, we investigated the effect of
vanillin inhalation on mouse behavior. First, we investigated whether the aroma of vanillin was attractive or
repulsive for mice. Thereafter, the mice inhaled vanillin for 20 min before each test in a series of behavioral tests
(elevated plus maze, open field, Y-maze, tail suspension, cotton bud biting, and Porsolt forced swim tests). In
these tests, the mice showed a neutral response to vanillin. Mice that inhaled vanillin had a suppressed pain
response in the hot plate test. In addition, the grip strength of the forelimbs of mice that inhaled vanillin was
decreased. No significant differences were found between the mice inhaling vanillin and control mice in the open
field, Y-maze, tail suspension, forced swimming, and aggression tests. These results show that vanillin inhalation
has anti-nociceptive effects, similar to other routes of administration. The results also show that vanillin in-
halation does not cause significant behavioral effects.
1. Introduction
In recent years, there has been increasing interest in alternative
medicine, including aromatherapy. Aromatherapy is a type of com-
plementary medicine widely used for the management of chronic pain,
depression, anxiety, insomnia, and stress-related disorders [1,2]. Es-
sential oils used in aromatherapy are believed to have a physiological
effect [3–5]. Essential oils are absorbed into the olfactory and re-
spiratory systems by inhalation or are transdermally incorporated into
the body by massage [6]. Inhalation of essential oils transfers signals
from the olfactory system to the brain, and the brain regulates behavior
and mood by secreting neurotransmitters, such as serotonin and do-
pamine [1]. Therefore, various plant-derived essential oils have tradi-
tionally been used to treat psychiatric disorders, such as depression,
anxiety, neurosis, attention deficit hyperactivity disorder, and bipolar
disorder. However, the scientific basis for the effect of many essential
oils is lacking [2,7]. Moreover, the molecular mechanisms of action of
many inhaled scent molecules on the central nervous system are un-
known.
Vanillin (4-hydroxy-3-methoxybenzaldehyde) is the main compo-
nent of natural vanilla. Vanillin, a single molecule extracted from va-
nilla beans, is a common scent widely used in perfumes, foods, and
pharmaceuticals [8,9]. Vanillin is also present as a major component of
phenolic Styrax [10]. It has been reported that vanillin has antioxidant,
anti-inflammatory, anti-apoptotic, and anti-stress actions [11–14].
However, the exact pharmacological mechanism of action of vanillin
has not been elucidated. Although vanillin is included in many foods
and cosmetics due to its attractive aroma, the neuropsychological ef-
fects that occur following the inhalation of vanillin have not been
widely reported. Previous studies have reported that the inhalation of
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vanillin leads to increased appetite in mice [15]. This report shows that
vanillin readily passes through the blood-brain barrier and induces ef-
fects at the neuronal level. Therefore, we hypothesized that inhaled
vanillin may have neuropsychological effects. This study aims to clarify
the behavioral changes induced by the inhalation of vanillin in mice.
We also aimed to investigate whether inhaled vanillin caused an anti-
nociceptive effect.
2. Materials and methods
2.1. Animals
We used 11-week-old male C57BL/6 mice for these experiments.
The mice were randomly divided into two groups; one group was ex-
posed to vanillin (n = 10) and the other was not (n = 10). We pur-
chased the animals from Charles River Laboratories (Kanagawa, Japan)
and housed them in cages with food and water provided ad libitum
under a 12-/12-h light/dark cycle and a temperature range of
23 °C – 26 °C. We made every effort to minimize the suffering and
number of animals used. These experiments complied with the U.S.
National Institutes of Health (NIH) Guide for the Care and Use of
Laboratory Animals (NIH Publication No. 80-23, revised in 1996) and
were approved by the Committee for Animal Experiments at Kawasaki
Medical School Advanced Research Center.
2.2. Inhalation of vanillin
Vanillin was acquired from FUJIFILM Wako Pure Chemical
Corporation (224-00682, Osaka, Japan) and was diluted in distilled
water to obtain a concentration of 1% (v/v), immediately before the
experiments. We used 1% vanillin, which according to convention is the
concentration closest to the saturated solution [16]. Distilled water was
used as a control. The inhalation apparatus consisted of a custom-made
olfactometer. A piece of absorbent cotton (4 × 4 cm) impregnated with
2 mL of 1% vanillin was placed into the odor chamber
(150 × 100 × 100 mm). Clean air was introduced into the odor
chamber from a compressed air cylinder, and output odor air was used
for ventilation in the observation chamber (150 × 100 × 100 mm) at a
constant rate (5 L/min). After 10 min of pre-ventilation with odorous
air, each mouse was individually placed into the observation chamber.
The mice were subjected to vanillin for 20 min before each behavioral
test.
2.3. Odor preference test
The apparatus was rectangular (30 × 60 × 40 cm). Two transparent
cages (7.5 × 7.5 × 10 cm, with several holes 1 cm in diameter) were
placed at both the ends of the apparatus (Fig. 1A). Each mouse was
placed in the box for 6 min and was allowed free exploration to habi-
tuate. Exposure to olfactory stimuli was performed by gently impreg-
nating a piece of absorbent cotton (4 × 4 cm) with 1 mL of distilled
water or 1% vanillin. The absorbent cotton was placed in one of the
transparent cages that were located in the corners of each lateral
compartment. The subject mouse was placed at the center of the box
and was allowed to explore the entire box for 6 min. One side of the
rectangular area was identified as the vanillin area and the other as the
control area. The amount of time spent in each cage and around each
cage during the 6-min sessions was measured. The preference index for
vanillin was calculated as (time around vanillin/[time around con-
trol + time around vanillin]). All the components of the apparatus were
cleaned after each phase of this test. This test was conducted before the
other behavioral experiments. Data were video recorded and analyzed
using video tracking software (ANY-MAZE, Stoelting Co., Wood Dale,
IL, USA).
2.4. Behavioral tests
All behavioral experiments were performed during the light phase
(9:00–16:00). Each behavioral test was separated from the next by at
least one day. We tested the mice in a random order. After completion
of each test, the apparatus was cleaned with 70% ethanol and water
with superoxidized hypochlorous acid to prevent any bias due to ol-
factory cues.
2.4.1. Hot plate test
The hot plate test was used to evaluate nociception or sensitivity to
a painful stimulus [17]. Mice were placed on a hot plate at
55.0 °C ± 0.3 °C, and the latency to the first hind-paw response was
recorded. The hind-paw responses counted were foot shakes or paw
licks. A latency period of 30 s was defined as complete analgesia and
used as the cut-off time to prevent tissue injuries.
2.4.2. Neuromuscular strength evaluation
Neuromuscular strength was examined using the grip strength test.
A grip strength meter was used to assess forelimb grip strength. Mice
were lifted and held by the tail such that their forepaws could grasp a
wire grid; they were then pulled back gently until they released the
grid. The peak force applied by the forelimbs was recorded in Newton
(cN).
2.4.3. Cotton bud biting test
Aggressive behavior was examined using the cotton bud biting test
based on a previous study [18]. The mice were held in an experi-
menter’s hand, and a sterilized cotton bud was held close to their face.
Biting of the cotton bud was considered aggressive behavior. Each
mouse was tested 10 times. Analysis was conducted based on the total
number of biting attacks.
2.4.4. Elevated plus maze test
Anxiety-like behavior was examined using the elevated plus maze
test. The apparatus consisted of two open arms (8 × 25 cm) and two
closed arms of the same size with 30-cm-high transparent walls. The
arms were constructed using white plastic plates and were elevated to a
height of 40 cm above the floor. Arms of the same type were located
opposite each other. Each mouse was placed in the central square of the
maze, facing one of the closed arms, and was allowed to move freely
between the two arms for 10 min. The mice were video recorded and
the number of arm entries, distance traveled (m), and time spent in the
open arms were analyzed using the ANY-MAZE software.
2.4.5. Open field test
Exploratory behavior, anxiety-like behavior, and general activity
were examined using the open field test. In the open field test, each
mouse was placed in the center of the apparatus consisting of a square
area surrounded by high walls (40 × 40 × 40 cm). The total distance
traveled (m) and the time spent in the central area (s) were recorded.
The central area was defined as the 20 × 20 cm area located at the
center of the field. The test chamber was illuminated at 100 lx. Data
were collected over a 30-min period. Data analysis was performed au-
tomatically using the ANY-MAZE software.
2.4.6. Y-maze test
Spatial working memory was measured using a Y-maze apparatus
(arm length: 40 cm, arm bottom width: 3 cm, arm upper width: 10 cm,
height of wall: 12 cm). The mice were placed at the center of the Y-
maze field. Visual cues were placed around the maze in the testing
room and were constant throughout the testing sessions. Mice were
examined with no prior learning. The total distance traveled (m) and
the number of entries and alternations were recorded and analyzed
automatically using the ANY-MAZE software. Data were collected for
10 min.
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2.4.7. Tail suspension test
Depressive-like behavior was examined using the tail suspension
test and Porsolt forced swim test (PFST). Each mouse was suspended by
the tail at 60 cm above the floor in a white plastic chamber using ad-
hesive tape placed < 1 cm from the tip of the tail. The resultant beha-
vior was recorded for 10 min. Images were captured via a video camera,
and immobility time was measured. In this test, the ‘immobile period’
was defined as the period when the animals stopped struggling for
≥1 s. Data acquisition and analysis were performed automatically
using ANY-MAZE software.
2.4.8. Porsolt forced swim test
The apparatus for the PFST consisted of four Plexiglas cylinders (20-
cm height × 10-cm diameter). The cylinders were filled with water
(23 °C) up to a height of 7.5 cm, based on previous studies [19,20]. The
mice were placed into the cylinders, and their behavior was recorded
over a 10-min test period. As in the tail-suspension test, immobility
time was evaluated using the ANY-MAZE software.
2.5. Statistical analyses
Data were analyzed using one-way analysis of variance (ANOVA)
followed by Tukey’s test and two-way repeated measures ANOVA
followed by Fisher’s LSD test, Student’s t-test, or paired t-test.
Differences with a p-value < 0.05 were regarded as statistically sig-




We examined whether mice found vanillin attractive or repulsive.
No differences were observed in the time spent in the different areas of
the apparatus, the number of entries around the cage, or the time spent
around the cage (Fig. 1B, t = 0.123, p = 0.901; Fig. 1C, t = 0.13,
p = 0.898; Fig. 1D, t = 0.246, p = 0.809). The vanillin preference
index was approximately 0.5 (Fig. 1E).
3.2. Effect of vanillin on neuromuscular strength and aggressive behavior
To evaluate the acute phase response rapidly and assess acute,
thermal pain in a relatively inexpensive way, we used the hot plate test.
Mice were placed on a hot plate to assess nociception. Mice exposed to
vanillin had a significantly higher pain threshold than did control mice
(Fig. 2A, t = 3.126, p = 0.006).
Fig. 1. Vanillin preference in mice.
(A) Schematic diagram of the odor preference test. (B–E) Graphs
showing the time spent in each area (B), number of entries around
the cage (C), time spent around the cage (D), and 2-PE preference
index (E). All data are presented as box plots. *, significant dif-
ference compared to control (p < 0.05). The p-values in B, C, and
D were calculated using the Student’s t-test. (B–E) n = 20.
Fig. 2. Effect of vanillin on normal physical characteristics and
aggressive behavior.
(A) Hot plate test. (B) Grip strength. (C) Number of times biting on
the cotton bud. All data are presented as box plots. *, significant
difference compared to control (p < 0.05). The p-values were
calculated using the Student’s t-test. (A–C) control: n = 10, va-
nillin: n = 10.
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We compared the neuromuscular strength of mice exposed to va-
nillin and control mice. The grip strength was significantly lower in
mice exposed to vanillin (Fig. 2B, t = 2.217, p = 0.04).
We evaluated the aggressive behavior of mice after vanillin in-
halation. There were no significant differences in the number of biting
attacks between mice exposed to vanillin and control mice (Fig. 2C,
t = 1.678, p = 0.111).
3.3. Effect of vanillin in the elevated plus maze test
In the elevated plus maze test, we evaluated anxiety-like behavior in
mice after vanillin inhalation. No differences were observed in the total
distance traveled (Fig. 3A, t = 0.042, p = 0.967) or the time spent in
the open arms (Fig. 3C, t = 0.706, p = 0.245) between mice exposed to
vanillin and control mice. The number of total entries into open arms
was significantly lower in mice exposed to vanillin than in control mice
(Fig. 3B, t = 2.266, p = 0.036).
3.4. Effect of vanillin in the open field test
In the open field test, we observed no significant difference in the
total distance traveled (Fig. 3D, F1,18 = 1.292, p = 0.271) or the time
spent in the central area (Fig. 3E, F1,18 = 0.043, p = 0.837) between
the two groups.
3.5. Effect of vanillin in the Y-maze test
We examined the effect of vanillin on short-term spatial working
memory by monitoring spontaneous alternation behavior in the Y-maze
test. There were no significant differences between the groups in the
total distance traveled (Fig. 3F, t = 0.53, p = 0.602), number of arm
entries (Fig. 3G, t = 1.0, p = 0.329), or alternation percentage (Fig. 3H,
t = 0.653, p = 0.522).
Fig. 3. Effect of vanillin on performance on the
elevated plus maze, open field, and Y-maze
tests.
(A–C) Elevated plus maze test. Graphs showing
the total distance traveled (A), the percentage
of open arm entries (B), and the time spent in
the open arms (C) in the elevated plus maze
test. (D–E) Open field test. Graphs showing the
distance traveled (D) and time spent in the
central area (E) in each 5 min-period of the
open field test. (F–H) Y-maze test. Graphs
showing the total distance traveled (F), total
number of arm entries (G), and percentage of
alternations (H). All data are presented as box
plots. *, significant difference compared to
controls (p < 0.05). The p-values were calcu-
lated using the Student’s t-test in A–C, and F–H
and two-way repeated measures analysis of
variance in D and E. (A–H) control: n = 10,
vanillin: n = 10.
H. Ueno, et al. Biomedicine & Pharmacotherapy 115 (2019) 108879
4
3.6. Effect of vanillin on depressive-like behavior in mice
We evaluated depressive-like behavior in mice after vanillin in-
halation. In the tail-suspension test, we found no significant differences
between groups with regard to the percentage of time spent immobile
(Fig. 4A, t = 1.18, p = 0.254; Fig. 4B, F1,18 = 1.386, p = 0.254). In the
PFST, no significant differences were observed between the groups
(Fig. 4C, t = 0.806, p = 0.431; Fig. 4D, F1,18 = 0.641, p = 0.434).
4. Discussion
In this study, we showed that the inhalation of vanillin has anti-
nociceptive and muscle relaxant effects in mice. The mice that inhaled
vanillin did not show significant changes compared with control mice
in the other behavioral tests.
Vanillin is regarded as an attractive fragrance for people and is
considered as an indispensable material for foods and perfumes. In fact,
vanillin exposure is considered to be generally comfortable for humans
and is said to induce a positive mood [21]. However, it is difficult to
examine the physiological actions of vanillin in humans. In the present
study, mice showed behavior that indicated that vanillin was neither
attractive nor repellent. However, since we performed the odor
preference test in an open area, it is possible that the odor of vanillin
had diffused through the whole apparatus, and thus, the mice did not
show a positive result for vanillin. However, it has been previously
shown that mice positively approach fragrant objects [22]. In previous
studies, it has been reported that mice exhibit neutral behavior against
vanillin [23]. This is in line with our results that show that vanillin does
not induce anxiety or aggression in mice.
Mice that had inhaled vanillin showed anti-nociceptive effects in the
hot plate test. Previous studies have shown that oral administration of
vanillin to mice has an anti-nociceptive effect in the acetic acid writhing
test [11,24]. Furthermore, oral administration of vanillin to rats has
been reported to reduce allodynia induced by chronic constriction of
the sciatic nerve [25]. These reports are consistent with the results of
this study, which show that vanillin has an anti-nociceptive effect.
Vanillin is the only trioxide essential oil component for which anti-
nociceptive activity has been reported [11,26]. Vanillin contains three
highly reactive functional groups in its structure: aldehydes, phenols,
and ethers [27]. Vanillin has numerous structural similarities with
other compounds like eugenol, zingerone, and capsaicin and can po-
tentially exhibit similar pharmacological activity via the vanilloid re-
ceptor. A limited number of natural substances exhibit agonist/an-
tagonist activity towards the vanilloid receptor. The structural features
Fig. 4. Effect of vanillin on depressive-like behavior.
Graphs showing the proportion of total time spent immobile (A) and the proportion of time spent immobile in each 1-min period (B) in the tail suspension test.
Graphs showing the proportion of total time spent immobile (C) and the proportion of time spent immobile in each 1-min period at day 1 (D) and in the Porsolt forced
swim test. All data are presented as box plots. *, significant difference compared to controls (p < 0.05). The p-values were calculated using the Student’s t-test in A
and C, and two-way repeated measures analysis of variance in B and D. (A–D) control: n = 10, vanillin: n = 10.
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of these molecules include a vanillyl (3-methoxy-4-hydroxyphenyl)
group. Many vanilloid substances, such as capsaicin and resinifera
toxin, have analgesic activity by agonistically desensitizing transient
receptor potential-vanilloid 1 (TRPV1) channels found in dorsal roots
and trigeminal ganglia [28–30]. Furthermore, vanillin has also been
reported to exhibit potential central anti-nociceptive effects mediated
through opioid receptors [31]. This anti-nociceptive action of vanillin
may be mediated by the α2-adrenoceptor and the opioid receptor, but
not by the α1-adrenoceptor and the serotonin receptor [11].
It is reported that eugenol containing a vanillyl group shows an
appetite-enhancing effect like vanillin [32]. Moreover, eugenol is used
as a dental analgesic [33,34], while the administration of eugenol to
mice has a muscle relaxant effect [35]. As described above, vanillin may
bind to the vanilloid receptor in the same manner as eugenol and thus
produce an analgesic effect and a muscle relaxation effect. The muscle
relaxing action of vanillin has not been reported so far. However, it has
been reported that vanillin promotes arterial relaxation by blocking Ca2
channels [36]. Vanillin also acts on ileal smooth muscle calcium
channels and prevents acetylcholine-induced contraction via non-
competitive inhibitory kinetics [37]. Vanillin may promote its muscle-
relaxing effect by altering tissue blood flow by intramuscular vasodi-
lation [38].
Although the mechanism of action of inhaled vanillin is unknown, it
is presumed to have a similar mechanism of action to that of orally
administered vanillin. However, further studies are needed to elucidate
the analgesic mechanism of action of inhaled vanillin.
In this study, we showed that the anti-nociceptive effect of vanillin
can be demonstrated by the inhalation of vanillin in mice. Linalool, one
of the major odor components of lavender extract, is known to reduce
the pain response when injected subcutaneously [39,40]. In recent
years, however, inhaled linalool was also shown to alleviate pain [41].
The analgesic effects of the inhalation of fragrance molecules have not
been sufficiently investigated. More importantly, it is not clear how
scent molecules act on nerves following inhalation. One likely hy-
pothesis is that the volatile compound acts by entering the bloodstream
via the nasal or pulmonary mucosa. The skin permeability of a drug has
a high correlation with its lipid solubility or lipophilicity [42]. Drugs
with molecular weights up to 100 are easily absorbed from the nasal
mucosa [43]. Since vanillin is a low-molecular-weight molecule and is a
lipophilic chemical substance, it is thought to be easily absorbed from
the nasal mucosa. This chemical is expected to have good permeability
in brain tissue.
In this study, we used an significantly higher vanillin concentration
than that used in foods. It is not clear whether a pharmacological effect
is exhibited in humans due to the ingestion of vanillin from foods and
cosmetics. Further studies are needed to investigate whether the effect
of vanillin is dependent on the concentration of vanillin in the air. It is
also necessary to investigate the concentration threshold at which va-
nillin exhibits its physiological actions.
This study showed that the inhalation of vanillin increased anxiety-
like behavior in mice in the elevated plus maze test. However, in the
open field test, no change was observed between mice inhaling vanillin
and control mice with regard to anxiety-like behavior. Therefore, the
vanillin-induced anxiety results were not consistent between the open
field and elevated plus maze test. This difference is presumed to be due
to anxiety about wide spaces and heights [44]. The influence of vanillin
on anxiety-like behavior is unknown, but the mice may feel anxious
owing to the muscle relaxation effect of vanillin. Administration of a
muscle relaxant to mice reduces the number of entries into the open
arm of the elevated plus maze test [45]. In addition, compounds that
exhibit anti-anxiety effects may have side-effects such as insomnia and
muscle relaxation [46]. Further studies are necessary to clarify the in-
fluence of vanillin on anxiety-like behavior. The relationship between
the analgesic activity and muscle relaxation activity of vanillin has not
been reported so far. However, most of the centrally acting analgesics
have central nervous system depressant effects, and thus affect
locomotor activity by reducing motor activity [47]. Locomotor activity
is considered an indicator of arousal or alertness of mental activity, and
a decrease in activity is an indicator of calmness and sedation as a result
of reduced excitability of the central nervous system [48].
The rate of vanillin metabolism in the live body is unknown.
Therefore, even in this study, there is a possibility that vanillin re-
mained in the body in the days following the day of administration. As
humans frequently inhale vanillin in daily life, further studies to in-
vestigate the pharmacokinetics of vanillin in the body are also neces-
sary.
No significant differences were found between the mice inhaling
vanillin and control mice in the open field, Y-maze, tail suspension, and
forced swimming tests. It has been reported that vanillin may attenuate
cognitive decline in a mouse model of cognitive dysfunction [13].
However, it has not been reported whether vanillin can improve the
cognitive function in naïve mice. On the other hand, vanillin has been
reported to have an antidepressant effect [49]. The difference between
the previous report and this study may be due to the administration
method and dose. Considering that there are few articles on clinical
trials and animal experiments related to the effects of vanillin, the re-
sults of this study are believed to be reasonable.
This study is the first to report the effect of vanillin inhalation on
behavior in mice. It is also the first to report the anti-nociceptive effect
of vanillin inhalation. Our findings demonstrate a scientific basis for the
effect of vanillin, which complements previous studies on vanillin ar-
omatherapy.
5. Conclusions
Inhalation of vanillin has anti-nociceptive and muscle relaxant ef-
fects and may increase anxiety-like behavior in mice. However, the
inhalation of vanillin had no effect on mouse activity or cognitive
function. This study provides a scientific basis for the neuropsycholo-
gical effects of essential oils containing vanillin. Inhalation of essential
oils containing vanillin may lead to effective sedation.
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